Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04279639
Other study ID # 1021299
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 13, 2016
Est. completion date October 31, 2017

Study information

Verified date February 2020
Source Nova Scotia Health Authority
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This observational study documented outcomes resulting from qigong practice as a complementary self-care practice. All subjects continued with their usual medical care. Recruitment was passive, and participants consisted of those who encountered the practice as part of an earlier clinical trial, or entered the program prior to the observational period (posted information, word-of-mouth), or entered during the observational period (posted information).


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date October 31, 2017
Est. primary completion date October 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Those undertaking qigong practice as a complementary self-care practice at the Pain Management Unit

Exclusion Criteria:

- None

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
qigong
Patients of the Pain Management Unit either experience usual treatment, or usual treatment plus qigong practice.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Nova Scotia Health Authority

Outcome

Type Measure Description Time frame Safety issue
Primary Brief Pain Inventory Brief Pain Inventory, short form. Minimum is 0 (no pain), maximum is 10 (most pain) 8 week intervals
Secondary Profile of Mood States Profile of Mood States. Minimum is 30 (less depressed), maximum is 150 (more depressed) 8 week intervals
Secondary health-related quality of life Short Form-12 item, Version 2 (SF-12V2). Minimum is 12 (lowest Quality of life), maximum is 56 (best Quality of life) 8 week intervals
Secondary Sleep Pittsburg Sleep Quality Index. Minimum is 0 (best sleep), maximum is 21 (poor sleep). 8 week intervals
Secondary Fatigue Chronic Fatigue Scale. Minimum is 0 (no fatigue), maximum is 42 (most fatigue). 8 week intervals
Secondary Practice log Weekly Practice log 8 week intervals
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain